ANIXNasdaqPharmaceutical PreparationsFiscal year ends October 31
Anixa Biosciences Inc
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 9, 2026
$2.61−0.06 (-2.25%)
Close on Oct 19, 2026
- Market cap
- $89.22M
- P/E (TTM)
- –
- Dividend yield
- –
Anixa Biosciences statistics
Financials through Jul 31, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Anixa Biosciences | Industry median |
|---|---|---|
| Market Cap | $90.73M | $197.05M |
| Enterprise Value | $75.60M | $106.56M |
| PB Ratio | 6.27 | 2.14 |
| P/TBV Ratio | 6.27 | 2.46 |
Income (trailing twelve months)
| Measure | Anixa Biosciences | Industry median |
|---|---|---|
| Operating Income | -$10.98M | -$21.44M |
| Net Income | -$10.38M | -$22.46M |
| EBITDA | -$10.98M | -$16.91M |
Returns
| Measure | Anixa Biosciences | Industry median |
|---|---|---|
| Return on Equity (ROE) | -66.8% | -53.1% |
| Return on Assets (ROA) | -63.4% | -41.0% |
| Return on Invested Capital (ROIC) | -1478.4% | -32.0% |
| Return on Capital Employed (ROCE) | -82.3% | -37.8% |
Balance sheet
| Measure | Anixa Biosciences | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $13.86M | $62.42M |
| Net Cash (Debt) | $13.86M | $15.68M |
| Net Cash Per Share | $0.40 | $0.65 |
| Equity (Book Value) | $14.47M | $48.79M |
| Book Value Per Share | $0.42 | $1.36 |
| Tangible Book Value | $14.47M | $23.06M |
| Working Capital | $13.17M | $75.77M |
Financial position
| Measure | Anixa Biosciences | Industry median |
|---|---|---|
| Current Ratio | 8.54 | 3.30 |
| Quick Ratio | 7.94 | 2.39 |
Cash flow (trailing twelve months)
| Measure | Anixa Biosciences | Industry median |
|---|---|---|
| Operating Cash Flow | -$7.38M | -$12.35M |
Efficiency
| Measure | Anixa Biosciences | Industry median |
|---|---|---|
| Profits Per Employee | -$2.60M | -$732.08K |
| Employee Count | 4 | 73 |
Dividends and yields
| Measure | Anixa Biosciences | Industry median |
|---|---|---|
| Earnings Yield | -11.4% | -21.2% |
Shares
| Measure | Anixa Biosciences | Industry median |
|---|---|---|
| Shares Outstanding | 34,763,800 | 59,128,900 |
| Shares Change (QoQ) | 1.95% | 0.54% |
| Float | 24,890,400 | 48,744,500 |
| Shares Held by Insiders | 28.4% | 11.8% |
| Shares Held by Institutions | 15.4% | 59.4% |
Scores
| Measure | Anixa Biosciences | Industry median |
|---|---|---|
| Altman Z-Score | 3.62 | 0.10 |
| Piotroski F-Score | 2 | 4 |
Calculated by StockData from Anixa Biosciences's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.